March 9, 2026 Capitol Hill Report: Our 2026 Advocacy Priorities

March 9, 2026 Capitol Hill Report: Our 2026 Advocacy Priorities

In this episode, Dr. Jason Crowell reviews the March 9th Capitol Hill Report discussing the AAN's advocacy priorities for 2026.

Stay updated with what's happening on the hill by visiting aan.com/chr.

Learn how you can get involved with AAN advocacy.

Show transcript:

Dr. Jason Crowell:

Hey, this is Jason Crowell. Thanks for listening to today's Neurology Minute. Today, we have an advocacy update from the AAN's Capitol Hill Report. The AAN has come out with its top advocacy priorities for 2026, and the first is access to care which includes affordable prescription drug prices, telehealth, and adequate coverage policies. Neurological conditions can require expensive specialty drugs as we know, so the AAN supports policies that ensure prescription medications are accessible to patients. Related to this priority, the Center for Medicare and Medicaid Innovation recently announced the GLOBE and GUARD models, two proposed mandatory drug pricing models that would make manufacturers pay rebates if their drug prices exceed global benchmarks. The AAN has responded to these proposals with recommendations to avoid unintended access issues. It's also important to make telehealth flexibilities permanent for Medicare beneficiaries, and the AAN has been lobbying for the CONNECT for Healthcare Act to do that.

The second top priority is reducing regulatory and administrative burdens, like prior authorization and step therapy which we're familiar with. This is a longtime problem for physicians who spend a lot of time each week. We deal with these processes and we'd rather be treating patients, as you know. A new Medicare initiative called the WISeR Model establishes new prior authorization requirements for some medical services, and while it doesn't directly affect neurology, the AAN and other organizations are pushing back and closely monitoring for future similar models.

Next is the neurology workforce. This includes making sure Medicare reimbursement for neurological services is enough to maintain a practice, as well as supporting wellness and immigration policy to allow international medical graduates to practice in the US. Related to this priority, the AAN has been pushing for a permanent inflationary update to the Medicare Physician Fee Schedule and to end the schedule's outdated budget neutrality requirement that ends up causing cuts to reimbursement each year.

The final priority is neuroscience research and brain health. There have been a lot of threats to research funding recently, and the AAN has been lobbying for NIH and NINDS funding that includes the BRAIN Initiative, an important program that's led to neurology breakthroughs. It's set to lose a big part of this funding at the end of the year when funding from the 21st Century Cures Act expires. So the AAN has been asking Congress to help make up the gap through appropriation spending.

There's much more in this week's Capitol Hill Report, and this is available on aan.com/chr, and for our US members, you can also find this Capitol Hill Report in your inbox. So check it out to learn more.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(2007)

Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments - Part 1

Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments - Part 1

In the first installment of this series, Dr. Aaron Zelikovich and Dr. Bhaskar Roy discuss how emerging treatments for myasthenia gravis compare to one another.  Show citation:  McLaren NP, Rosati M, Z...

4 Syys 1min

National Trends in Medicare Charges and Reimbursement for Inpatient Neurologic Care

National Trends in Medicare Charges and Reimbursement for Inpatient Neurologic Care

Dr. Jason Crowell and Ka-Ho Wong discuss national trends in Medicare reimbursement for inpatient neurologic care.  Show citation:  Wong KH, Castillo M, King J, et al. National Trends in Medicare Charg...

3 Syys 2min

Updates in Neuroinfectious Disease - Part 3

Updates in Neuroinfectious Disease - Part 3

In the third episode of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss HSV encephalitis and dexamethasone.

2 Syys 5min

Updates in Neuroinfectious Disease - Part 2

Updates in Neuroinfectious Disease - Part 2

In part two of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss pegivirus-associated encephalomyelitis.

1 Syys 5min

Updates in Neuroinfectious Disease - Part 1

Updates in Neuroinfectious Disease - Part 1

In part one of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss acute necrotizing encephalopathy.

31 Elo 4min

2026 Alzheimer's Association International Conference - Part 1

2026 Alzheimer's Association International Conference - Part 1

In part one of this series, Drs. Greg Cooper, Trey Bateman, and Gregg Day discussed key takeaways from the 2026 Alzheimer's Association International Conference, focusing on blood-based biomarkers, an...

27 Elo 1min

Recap from the 2026 AAN Autoimmune Neurology Conference

Recap from the 2026 AAN Autoimmune Neurology Conference

Dr. Justin Abbatemarco recaps a presentation on Hashimoto encephalopathy from the AAN Autoimmune Neurology Conference.   Show citation:    Valencia-Sanchez C, Pittock SJ, Mead-Harvey C, et al. Brain d...

26 Elo 2min

Lab Minute: Vitamin B12

Lab Minute: Vitamin B12

In this lab minute, Dr. Stacey Clardy reviews the role of vitamin B12 testing in neurologic practice.

25 Elo 4min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
aamukahvilla
vakeva-elama-viisaampi-mieli-vahvempi-keho
psykopodiaa-podcast
tiedenaiset-podcast
rss-pitaisko-erota
meditaatiot-suomeksi
rss-kuumilla-aalloilla
terapiassa
voi-hyvin-meditaatiot-2
katilon-kahvitunti
selviytyjat-tarinoita-elamasta
rss-uplevel-by-sonja-hannus
rss-pt-paahtio
fitnessvastaanotto
rss-vapaudu-voimaasi
rss-mighty-finland-podcast
rss-en-saa-unta
yes-girl
rss-8-oppituntia-rohkeudesta